Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,228 | 38 | 97.6% |
| Education | $29.99 | 1 | 2.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sunovion Pharmaceuticals Inc. | $600.36 | 22 | $0 (2017) |
| Allergan Inc. | $304.90 | 6 | $0 (2018) |
| Otsuka America Pharmaceutical, Inc. | $222.68 | 2 | $0 (2017) |
| Lundbeck LLC | $65.36 | 4 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $48.20 | 4 | $0 (2018) |
| Takeda Pharmaceuticals America, Inc. | $16.35 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2018 | $68.77 | 4 | Allergan Inc. ($43.23) |
| 2017 | $1,189 | 35 | Sunovion Pharmaceuticals Inc. ($600.36) |
All Payment Transactions
39 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/25/2018 | Allergan Inc. | VRAYLAR (Drug) | Education | In-kind items and services | $29.99 | General |
| Category: NEUROSCIENCE | ||||||
| 04/13/2018 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug) | Food and Beverage | In-kind items and services | $11.94 | General |
| Category: NEUROSCIENCE | ||||||
| 02/16/2018 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.24 | General |
| Category: NEUROSCIENCE | ||||||
| 01/05/2018 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug) | Food and Beverage | In-kind items and services | $13.60 | General |
| Category: NEUROSCIENCE | ||||||
| 12/07/2017 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $124.60 | General |
| Category: PSYCHIATRY | ||||||
| 11/01/2017 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $12.30 | General |
| Category: CNS | ||||||
| 10/18/2017 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: CNS | ||||||
| 10/04/2017 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $17.00 | General |
| Category: CNS | ||||||
| 09/22/2017 | Lundbeck LLC | TRINTELLIX (Drug) | Food and Beverage | Cash or cash equivalent | $20.12 | General |
| Category: PSYCHIATRY | ||||||
| 09/20/2017 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $10.39 | General |
| Category: CNS | ||||||
| 09/08/2017 | Lundbeck LLC | ABILIFY MAINTENA (Drug) | Food and Beverage | Cash or cash equivalent | $10.93 | General |
| Category: PSYCHIATRY | ||||||
| 09/06/2017 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $15.77 | General |
| Category: CNS | ||||||
| 09/01/2017 | Merck Sharp & Dohme Corporation | — | Food and Beverage | In-kind items and services | $10.69 | General |
| 08/23/2017 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $15.95 | General |
| Category: CNS | ||||||
| 08/10/2017 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $11.93 | General |
| Category: NEUROSCIENCE | ||||||
| 08/09/2017 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $10.29 | General |
| Category: CNS | ||||||
| 07/28/2017 | Lundbeck LLC | TRINTELLIX (Drug) | Food and Beverage | Cash or cash equivalent | $16.68 | General |
| Category: PSYCHIATRY | ||||||
| 07/26/2017 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: CNS | ||||||
| 07/12/2017 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $16.81 | General |
| Category: CNS | ||||||
| 06/28/2017 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $18.39 | General |
| Category: CNS | ||||||
| 06/23/2017 | Takeda Pharmaceuticals America, Inc. | Trintellix (Drug) | Food and Beverage | In-kind items and services | $16.35 | General |
| Category: Central Nervous System (CNS) | ||||||
| 06/23/2017 | Merck Sharp & Dohme Corporation | BELSOMRA (Drug) | Food and Beverage | In-kind items and services | $11.97 | General |
| Category: NEUROSCIENCE | ||||||
| 06/14/2017 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $21.42 | General |
| Category: CNS | ||||||
| 06/07/2017 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $109.41 | General |
| Category: CNS | ||||||
| 05/17/2017 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $110.44 | General |
| Category: CNS | ||||||
About Dr. Thomas Powers, M.D
Dr. Thomas Powers, M.D is a Psychiatry healthcare provider based in Castro Valley, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1780778407.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thomas Powers, M.D has received a total of $1,258 in payments from pharmaceutical and medical device companies, with $68.77 received in 2018. These payments were reported across 39 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($1,228).
Practice Information
- Specialty Psychiatry
- Location Castro Valley, CA
- Active Since 10/03/2006
- Last Updated 07/09/2007
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1780778407
Products in Payments
- LATUDA (Drug) $600.36
- VRAYLAR (Drug) $304.90
- ABILIFY MAINTENA (Drug) $233.61
- TRINTELLIX (Drug) $54.43
- BELSOMRA (Drug) $37.51
- Trintellix (Drug) $16.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.